PathoVax LLC is a Johns Hopkins start-up biotechnology company headquartered in Baltimore, Maryland. Founded in 2014, the company has been focused on different medical applications for its proprietary Papillomavirus Virus-like Particle (VLP) platform.
Management & Operations Team
Joshua Wang Ph.D.
Co-Founder & CEO
Wenbin Lai Ph.D., MBA
Chemistry, Manufacturing & Controls Advisor (Singapore)
Robert "Bob" Becker Ph.D., MBA
Business Management
Jay Nadkarni, MBA
Partnerships
Business Advisory Board
Robert Silverman
Chairman of Business Advisory Board
Eric Richman, MBA
Business Advisor
Roger Pomerantz M.D., FACP
Business Advisor
Solomon Langermann, Ph.D
Business Advisor
Scientific, Clinical Advisory Board, and Collaborators
Richard Roden, Ph.D
Co-director of Viral Oncology, Johns Hopkins School of medicine
Reinhard Kirnbauer, MD
Director of Viral Oncology,
Medical University Vienna
Warner Huh, M.D
Professor and Division Director of the Division of Gynecologic Oncology at the University of Alabama at Birmingham.
